Skip to main content
Tech.euFundingExplorerBeta

Tetra Pharm Technologies

Biotech company focused on therapeutics targeting the endocannabinoid system

Tetra Pharm Technologies has raised €9.0M across 1 funding round from 5 investors, most recently a Series A round in Jan 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€9.0M
€9,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2023-01
latest 2023-01

Funding by year

EUR raised per year
Tetra Pharm Technologies — funding by year — interactive chart.
Data table
Tetra Pharm Technologies — funding by year
2023€9.0M

Signals

High confidence
Raise-next likelihood8
base rate 44% for Series A
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2023-01-26Series A€9.0MEnexis AB,Leafy Tunnel,Nesroht Holding,Ole GS Holding,Rump InvestView deal →

Similar companies

same sector or country

Global coverage: FundingData